Stay updated with breaking news from Regeneron Eylea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to Spherix Global Insights' Launch Dynamix™: Vabysmo service, to no surprise, Regeneron's Eylea continues to lead the charge in both...
The Financial Times has reported that the Dutch Pharmaceutical Accountability Foundation (PAF), a public interest group, is suing AbbVie for…
Apellis has successfully guided its C3 complement inhibitor Pegcetacoplan to approval in paroxysmal nocturnal hemoglobinuria. Click here to read my analysis.
/PRNewswire/ -- The switch landscape represents an active segment of the market where brands have the opportunity to capture share. Spherix's RealWorld...
/PRNewswire/ -- Ophthalmologists saw the entry of the first biosimilars into the armamentarium in 2022 with the launch of Biogen and Samsung's Byooviz and...